Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Friede

Showing results (181-190 of 393) with videos related to

Pageof 40
Sort By:
ESC Heart Failure|July 21, 2025
Rationale and design of the randomized 'early ventricular assist device'-Trial (VAD-DZHK3)Christoph Knosalla, Gloria Färber, Andreas J Rieth, et al.
BMC Primary Care|April 27, 2023
Evaluating an app for digital medical history taking in urgent care practices: study protocol of the cluster-randomized interventional trial 'DASI'Eva Maria Noack, Dagmar Zajontz, Tim Friede, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Fasudil attenuates disease spreading in ALS - a post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Blood Purification|September 12, 2013
Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating diseaseMichael Koziolek, Johannes Mühlhausen, Tim Friede, et al.
BMC Family Practice|June 3, 2014
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary careJean-François Chenot, Thanh Duc Hua, Manar Abu Abed, et al.
European Journal of Clinical Investigation|April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational studyPaulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Systematic Reviews|September 8, 2023
Adherence enhancing interventions for pharmacological and oxygen therapy in patients with COPD: protocol for a systematic review and component network meta-analysesOmar Ammous, Stefan Andreas, Tim Friede, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 3, 2026
Effects of fasudil on disease spreading in ALS - A MUNIX-based post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
BMC Complementary and Alternative Medicine|July 5, 2018
Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) - a double-blind, randomized, controlled comparative effectiveness trialKambiz Afshar, Nina Fleischmann, Guido Schmiemann, et al.
Journal of Neurology|January 23, 2022
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regressionDimitrios Papadopoulos, Panagiotis Gklinos, Giorgos Psarros, et al.
Pageof 40

Showing results (181-190 of 393) with videos related to

Sort By:
Pageof 40
ESC Heart Failure|July 21, 2025
Rationale and design of the randomized 'early ventricular assist device'-Trial (VAD-DZHK3)Christoph Knosalla, Gloria Färber, Andreas J Rieth, et al.
BMC Primary Care|April 27, 2023
Evaluating an app for digital medical history taking in urgent care practices: study protocol of the cluster-randomized interventional trial 'DASI'Eva Maria Noack, Dagmar Zajontz, Tim Friede, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Fasudil attenuates disease spreading in ALS - a post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Blood Purification|September 12, 2013
Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating diseaseMichael Koziolek, Johannes Mühlhausen, Tim Friede, et al.
BMC Family Practice|June 3, 2014
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary careJean-François Chenot, Thanh Duc Hua, Manar Abu Abed, et al.
European Journal of Clinical Investigation|April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational studyPaulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Systematic Reviews|September 8, 2023
Adherence enhancing interventions for pharmacological and oxygen therapy in patients with COPD: protocol for a systematic review and component network meta-analysesOmar Ammous, Stefan Andreas, Tim Friede, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 3, 2026
Effects of fasudil on disease spreading in ALS - A MUNIX-based post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
BMC Complementary and Alternative Medicine|July 5, 2018
Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) - a double-blind, randomized, controlled comparative effectiveness trialKambiz Afshar, Nina Fleischmann, Guido Schmiemann, et al.
Journal of Neurology|January 23, 2022
Disease-modifying treatments for multiple sclerosis have not affected the incidence of neoplasms in clinical trials over 3 decades: a meta-analysis with meta-regressionDimitrios Papadopoulos, Panagiotis Gklinos, Giorgos Psarros, et al.
Pageof 40